Page 55 - Product Testing News Today

Press release content from PR Newswire. The AP news staff was not involved in its creation. New Treatment for Severe Emphysema Now Covered Under Highmark Blue Cross Blue Shield January 18, 2021 GMT The FDA-Approved Olympus Spiration® Valve System Is a Breakthrough Device Used for the Therapeutic Treatment of Severe Emphysema, a Form of COPD. The FDA-Approved Olympus Spiration® Valve System Is a Breakthrough Device Used for the Therapeutic Treatment of Severe Emphysema, a Form of COPD. CENTER ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Business Wire. The AP news staff was not involved in its creation. Ixaka (formerly Rexgenero) Launches as an Integrated Cell and Gene Therapy Company January 18, 2021 GMT LONDON--(BUSINESS WIRE)--Jan 18, 2021-- Ixaka Ltd, an integrated cell and gene therapy company focused on the natural power of the body to cure disease, launches today. The Company’s shareholders have funded the business with over £40 million in financing. Previously Rexgenero Ltd, a UK-based comp...

Press release content from Business Wire. The AP news staff was not involved in its creation. Propanc Biopharma Receives Expression of Interest to Evaluate Proenzyme Therapy in Pancreatic and Ovarian Cancer Patients January 18, 2021 GMT MELBOURNE, Australia--(BUSINESS WIRE)--Jan 18, 2021-- Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in ... Agios Pharmaceuticals, Inc.January 17, 2021 GMT CAMBRIDGE, Mass., Jan. 17, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and genetically defined diseases, today reported a full analysis of the final data, including mature over...

Press release content from Business Wire. The AP news staff was not involved in its creation.

Press release content from Business Wire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Business Wire. The AP news staff was not involved in its creation.